INDV
NASDAQ · Pharmaceuticals
Indivior Pharmaceuticals Inc
$38.82
+0.15 (+0.39%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+14.65%
1Y
+76.05%
YTD
+8.65%
Open$38.83
Previous Close$38.67
Day High$38.91
Day Low$38.08
52W High$42.81
52W Low$17.10
Volume—
Avg Volume1.54M
Market Cap4.88B
P/E Ratio19.43
EPS$1.94
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$34.90
Above
SMA 200
$24.61
Above
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+24.9% upside
Current
$38.82
$38.82
Target
$48.50
$48.50
$40.68
$48.50 avg
$71.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.18B | 1.06B | 1.33B |
| Net Income | 200.03M | 161.89M | 235.99M |
| Profit Margin | 17.0% | 16.1% | 17.8% |
| EBITDA | 249.56M | 213.21M | 342.24M |
| Free Cash Flow | — | — | 277.67M |
| Rev Growth | +11.2% | +11.2% | +22.2% |
| Debt/Equity | 5.43 | 5.43 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 42.6 | 1.08T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.5 | 621.32B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 36.1 | 322.90B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 19.1 | 143.06B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 22.3 | 132.99B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.1 | 32.02B |